Israel Cancer Association - Annual Report 2023

Name of researcher

Institution

Research Subject

Funding received

Dr. Erez Hasnis

Rambam Medical Campus

Efficacy of Trametinib/ Hydroxychloroquine/L-Asparaginase Combination in Pancreatic Cancer

Dr. Ofrat Beyar Katz

Rambam Medical Campus

Dissecting the mechanism of response to thrombopoietin

receptor agonists in bone marrow aplasia following CAR-T cell therapy

Dr. Tamar Listovsky

Ariel University Advanced development of a small molecule that improves chemotherapy efficacy in solid tumors and reduces metastatic events

Prof. Tomer Kalisky

Bar Ilan University

Characterization of cell heterogeneity in kidney tumors using single-cell RNA isoform sequencing Acinar metaplastic cell identities dynamic during the malignant process and the correlation between the metaplastic gene signature and the prognosis zAVATAR- Zebrafish cancer “avatars” as platform for cancer personalized medicine Accurate functional analysis and classification of genetic variants of unknown significance associated with hereditary breast and ovarian cancer Investigating microbiome modulators of colorectal cancer signaling pathways Molecular Hallmarks of Human Oral Squamous Cell Carcinoma Assessing mechanisms of atherosclerosis induction by Immune Checkpoint Inhibitors and possible prevention strategies NSCLC organoid biobank to enhance personalized neoadjuvant chemo-immunotherapy treatments

Dr. Oren Parnas

Hebrew University

Dr. Rivka Ofir

Dead Sea & Arava Science Center

Prof. Efrat Levy Lahad Shaare Tzedek Medical Center

Prof. Eran Elinav

Weizmann Institute of Science Hebrew University

Dr. Katy Margulis

Dr. Ori Rahat

Rabin Medical Center Beilinson Campus

Dr. Ori Wald

Hebrew University

49